Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic's LINQ II cardiac monitor. The ...
HxM™ BT Solution Advantage The HxM™ BT Solution takes personal fitness monitoring to a new level. Real-time feedback including heart rate, speed and distance measures, combined with a focus on ...
Things are heating up for FIRE1, which posted a $120 million funding round to support its implant for tracking the hidden ...
FIRE1 has raised $120m in a financing round to advance its sensor that monitors important warning signs of heart failure (HF) ...
Fire1 announced today that it completed a $120 million financing round to accelerate the advancement of its heart failure ...
Fire1 secured funding from investors including Medtronic to move forward with a clinical trial of its remote heart failure ...
Dublin-based medtech Fire1 has raised $120m and received the ‘Breakthrough Device Designation’ from the US FDA for its Norm ...
Fire1 said Tuesday it raised $120 million to complete a pivotal trial of its Norm heart failure management system.
The emergence of adaptive cardiac devices, especially those that utilise AI, is propelling the wider industry shift towards ...